Analysis of Japanese Patients Treated with or without Long-Term Epirubicin Plus Ara-C Intravesical Instillation Therapy for Low-Grade Superficial Bladder Cancer

<div>Instillation group was treated using long-term intravesical instillation of 30 mg of epirubicin plus 200 mg of Ara-C dissolved in 20 mL of physiological saline.</div>

The Scientific World Journal

fig1

Figure 1

Figure 1: Analysis of Japanese Patients Treated with or without Long-Term Epirubicin Plus Ara-C Intravesical Instillation Therapy for Low-Grade Superficial Bladder Cancer 

Figure 1 | Analysis of Japanese Patients Treated with or without Long-Term Epirubicin Plus Ara-C Intravesical Instillation Therapy for Low-Grade Superficial Bladder Cancer 